An Indianapolis company plans to bring a new golf-based entertainment venue to northeast Fort Wayne ... located against the river on one side, (Eli) Lilly’s factory on the second side, Lilly ...

Ball State’s Hicks said biotech and drug manufacturers, including Indianapolis-based Eli Lilly and Co., could ... And Dan Starr, CEO of Fort Wayne-based Do it Best Corp., said this week that ...

Ball State’s Hicks said biotech and drug manufacturers, including Indianapolis-based Eli Lilly and Co., could see disruptions ... And Dan Starr, CEO of Fort Wayne-based Do it Best Corp., said this ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Teladoc and LifeMD are partnering with drugmaker Eli Lilly to offer the weight loss drug Zepbound directly to self-paying patients. The two telehealth companies said Thursday they’re working ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 33 trades. If we consider the specifics of each ...